Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.31002 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.28309 | 11 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.28372 | 11 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.23002 | 11 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.22366 | 11 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.34117 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.39603 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.25988 | 11 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.25391 | 11 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.27022 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.26711 | 11 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.25274 | 11 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.27231 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.27268 | 11 |